University Of Rhode Island

URI Prof. Yalda Shahriari awarded NSF grant to study Parkinson’s hallucinations using VR, aiming to identify neural markers for early detection and their relation to motor functions.

Four R.I. State Teachers of the Year will discuss teaching challenges and joys on Oct. 24, 6-8 p.m. at URI, moderated by Danielle Dennis. Panelists include Aimée Couto, Lisa Leaheey, Lisa Garcia, and Ashley Adamson. The discussion will cover changes in the profession, advice for new teachers, and family involvement in education.

Cybrexa Therapeutics initiates Phase 2 trial of CBX-12 in platinum-resistant or refractory ovarian cancer, following positive Phase 1 results showing 40% response rate in TOP1-naïve patients. CBX-12, a first-in-class peptide-drug conjugate, leverages alphalex™ technology for targeted delivery of exatecan, a potent TOP1 inhibitor, with broad activity across multiple solid tumor types and a favorable safety profile.

URI President Marc Parlange celebrated URI's growth and successes, including top rankings and record applications, aligning with the Focus URI strategic plan. He highlighted new campus projects and the importance of Question 2 on the November ballot for higher education bonds. Parlange also recognized student, faculty, and staff achievements, emphasizing URI's commitment to making education attainable for all.